Accessibility: Skip TopNav
PRP Monotherapy Reprograms the Chemo-resistant State
PRP Monotherapy Reprograms the Chemo-resistant State and Enhances Chemotherapeutic Response in Pancreatic Cancer
Format
JPEG
Quelle:
Propanc Biopharma, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein